Attached files
| file | filename |
|---|---|
| EX-99.1 - EXHIBIT 99.1 - FENNEC PHARMACEUTICALS INC. | tm205262d1_ex99-1.htm |
| EX-32.1 - EXHIBIT 32.1 - FENNEC PHARMACEUTICALS INC. | tm205262d1_ex32-1.htm |
| EX-31.2 - EXHIBIT 31.2 - FENNEC PHARMACEUTICALS INC. | tm205262d1_ex31-2.htm |
| EX-31.1 - EXHIBIT 31.1 - FENNEC PHARMACEUTICALS INC. | tm205262d1_ex31-1.htm |
| EX-23.1 - EXHIBIT 23.1 - FENNEC PHARMACEUTICALS INC. | tm205262d1_ex23-1.htm |
| 10-K - FORM 10-K - FENNEC PHARMACEUTICALS INC. | tm205262d1_10k.htm |
EXHIBIT 21
Fennec Pharmaceuticals Inc.
Subsidiaries
Oxiquant, Inc., a Delaware corporation
Fennec Pharmaceuticals, Inc., a Delaware corporation
Cadherin Biomedical Inc., a Canadian corporation
Fennec Pharmaceuticals (EU) Limited, an Irish Private Company Limited by Shares